Natalizumab in Multiple Sclerosis: Long-Term Management. [electronic resource]
Producer: 20180221ISSN:- 1422-0067
- Adrenal Cortex Hormones -- therapeutic use
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Humans
- Immunologic Factors -- administration & dosage
- JC Virus -- isolation & purification
- Leukoencephalopathy, Progressive Multifocal -- diagnosis
- Multiple Sclerosis -- drug therapy
- Natalizumab -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.